Abstract
Alcohol abuse, an increasing problem in developed societies, is one of the leading causes of acute and chronic pancreatitis. Alcoholic pancreatitis is often associated with fibrosis mediated by activated pancreatic stellate cells (PSCs). Alcohol toxicity predominantly depends on its non-oxidative metabolites, fatty acid ethyl esters, generated from ethanol and fatty acids. Although the role of non-oxidative alcohol metabolites and dysregulated Ca2+ signalling in enzyme-storing pancreatic acinar cells is well established as the core mechanism of pancreatitis, signals in PSCs that trigger fibrogenesis are less clear. Here, we investigate real-time Ca2+ signalling, changes in mitochondrial potential and cell death induced by ethanol metabolites in quiescent vs TGF-β-activated PSCs, compare the expression of Ca2+ channels and pumps between the two phenotypes and the consequences these differences have on the pathogenesis of alcoholic pancreatitis. The extent of PSC activation in the pancreatitis of different aetiologies has been investigated in three animal models. Unlike biliary pancreatitis, alcohol-induced pancreatitis results in the activation of PSCs throughout the entire tissue. Ethanol and palmitoleic acid (POA) or palmitoleic acid ethyl ester (POAEE) act directly on quiescent PSCs, inducing cytosolic Ca2+ overload, disrupting mitochondrial functions, and inducing cell death. However, activated PSCs acquire remarkable resistance against ethanol metabolites via enhanced Ca2+-handling capacity, predominantly due to the downregulation of the TRPA1 channel. Inhibition or knockdown of TRPA1 reduces EtOH/POA-induced cytosolic Ca2+ overload and protects quiescent PSCs from cell death, similarly to the activated phenotype. Our results lead us to review current dogmas on alcoholic pancreatitis. While acinar cells and quiescent PSCs are prone to cell death caused by ethanol metabolites, activated PSCs can withstand noxious signals and, despite ongoing inflammation, deposit extracellular matrix components. Modulation of Ca2+ signals in PSCs by TRPA1 agonists/antagonists could become a strategy to shift the balance of tissue PSCs towards quiescent cells, thus limiting pancreatic fibrosis.
Similar content being viewed by others
Introduction
Alcohol abuse is one of the major problems of modern societies, contributing to the development of many debilitating diseases—including acute pancreatitis (AP) and chronic pancreatitis (CP) [1, 2]. Although the incidence of pancreatic disorders is increasing globally, thus far, there is no authorised treatment available [3]. It is generally accepted that AP is initiated by toxic cytosolic Ca2+ signals in the pancreatic acinar cells (PACs), causing autodigestion due to premature activation of intracellular proteases and failure of mitochondrial ATP production. This results in necrosis of the enzyme-producing PACs [4, 5]. Alcohol-related AP is initiated by the powerful Ca2+-releasing effect of fatty acid ethyl esters (FAEEs), generated inside PACs by the non-oxidative combination of ethanol (EtOH) and fatty acids (FAs). The release of Ca2+ from intracellular stores, followed by Ca2+ release-activated Ca2+ entry from the extracellular fluid, causes the toxic global and sustained increase in the cytosolic Ca2+ concentration ([Ca2+]i), triggering alcohol-induced AP [4, 6, 7].
Pancreatic fibrosis, mediated by pancreatic stellate cells (PSCs) [1, 8], is a particularly frequent complication in alcoholic pancreatitis, but is much less common following other aetiologies [9,10,11]. In health, PSCs exist mainly in their quiescent phenotype, and are known to generate Ca2+ signals in response to physiological levels of bradykinin [4, 12, 13]. They become activated by mechanical stress or cytokines, e.g. transforming growth factor-beta (TGF-β) [12, 14, 15]. While activated PSCs play a role in tissue healing, prolonged inflammation can promote the persistent activation of these cells [12, 16, 17]. In such a scenario, PSCs repopulate tissue and deposit excessive amounts of extracellular matrix (ECM) components, resulting in organ dysfunction, diabetes, malnutrition and may contribute to an increased risk of pancreatic cancer [18, 19].
The role of Ca2+ in PACs and its relationship to the pathogenesis of AP is well established [4], but the signals that trigger pancreatic fibrosis are less clear. Activated cells are a dominant fraction of PSCs present during inflammation [14, 19], and it has been suggested that alcohol may contribute to PSC activation [20]. However, so far, it is unknown whether EtOH also affects Ca2+ homoeostasis in PSCs. Importantly, the progression from AP to fibrosis-associated CP is likely determined by the physiological consequences of PSC activation.
Here, we provide evidence that inducers of alcoholic pancreatitis act directly on PSCs, eliciting large and sustained Ca2+ responses in quiescent PSCs that cause cell death. However, as a result of significant alterations in Ca2+ homoeostasis, activated PSCs develop remarkable resistance to alcohol metabolites, which prevents them from dying. We also explored the mechanisms and candidates responsible for this phenomenon and discovered that the loss of the transient receptor potential ankyrin 1 channel (TRPA1) in activated PSCs is the main contributing factor. Our results prompt us to review the current dogmas on alcoholic pancreatitis to include the TRPA1 channel and TRPA1-dependent Ca2+ signals in PSCs as important players in the pathogenesis of this disease.
Results
EtOH and fatty acids induce pathophysiological Ca2+ responses in hPSCs
Since pathophysiological Ca2+ signalling in PACs directly triggers pancreatic pathology, we sought to investigate whether non-oxidative metabolites of alcohol and FAs can also affect Ca2+ homoeostasis in hPSCs. To address this, we monitored the real-time changes in the concentration of cytosolic Ca2+ ([Ca2+]i) of Fluo-4-loaded hPSCs (Fig. 1A), treated with EtOH and palmitoleic acid (POA) or palmitoleic acid ethyl ester (POAEE). Our cells responded to bradykinin, as was previously reported for mouse and human PSCs (Fig. 1B) [21,22,23]. Our new data revealed that EtOH (200 mM) induced only a very modest increase in [Ca2+]i of hPSCs (Fig. 1C, F). In contrast to EtOH alone, simultaneous application of EtOH with POA (concentrations of EtOH/POA were: 10 mM/10 µM, 25 mM/25 µM, 50 mM/50 µM and 100 mM/100 µM) caused a large and sustained elevation of [Ca2+]i in hPSCs (Fig. 1D). This increase was dose-dependent and most prominent for EtOH/POA 50 mM/50 µM (Fig. 1G). EtOH/POA 100 mM/100 µM induced such a dramatic [Ca2+]i overload that it killed a substantial fraction of hPSCs during the experiment, leading to the seemingly decreased response areas (Fig. 1G). Similarly, treatment with EtOH/POAEE 100 mM/100 µM and 200 mM/200 µM resulted in a global and prolonged elevation of [Ca2+]i in hPSCs (Fig. 1E) and the higher concentration had a more prominent effect (Fig. 1H).
A hPSCs loaded with Fluo-4-AM (Ca2+ probe): left—green fluorescence of Fluo-4; right—transmitted light. Scale bar: 40 µm. B Sample trace showing cytosolic Ca2+ responses in an hPSC to bradykinin (test for the physiological phenotype). C Cytosolic Ca2+ responses (average traces ± SEM) in hPSCs to 200 mM EtOH (n = 42, N = 5); control (average traces ± SEM) shows that the application of extracellular solution alone (NaHEPES with 1 mM Ca2+, n = 30, N = 3) does not trigger any Ca2+ responses in hPSCs. D Cytosolic Ca2+ responses (average traces ± SEM) in hPSCs to different concentrations of EtOH/POA [mM/µM]: 0 (Ctrl, same as in C, n = 30, N = 3), 10 (n = 21, N = 3), 25 (n = 24, N = 3), 50 (n = 29, N = 3) and 100 (n = 29, N = 3). E Cytosolic Ca2+ responses (average traces ± SEM) in hPSCs to EtOH/POAEE [mM/µM]: 0 (Ctrl, same as in C and D, n = 30, N = 3), 100 (n = 27, N = 3), 200 (n = 25, N = 3). F–H Bar charts show average response areas (±SEM) as well as individual response areas (black dots), which demonstrate an increase of Ca2+ above the baseline levels calculated between 200 and 800 s for all traces averaged in C, D and F, respectively. All data were compared to the same control (perfusion with the extracellular solution alone). I Schematic illustration of selected aspects of the cellular Ca2+ signalling machinery: cyclopiazonic acid (CPA) inhibits SERCA (sarco/endoplasmic reticulum Ca2+-ATPase), which blocks ER refilling and leads to emptying of this Ca2+ store. J Cytosolic Ca2+ responses (average traces ± SEM) induced in hPSCs in the absence of extracellular Ca2+ by different concentrations of EtOH/POA [mM/µM]: 0 (Ctrl, n = 21, N = 3), 10 (n = 14, N = 3), 25 (n = 19, N = 3) and 50 (n = 26, N = 3). K Bar chart shows the increase of Ca2+ above the baseline levels presented as average response areas (±SEM) and individual response areas (black dots) calculated between 200 and 800 s for all traces averaged in J. L Cytosolic Ca2+ response (representative trace) to 20 µM cyclopiazonic acid (CPA), an inhibitor of SERCA (as depicted in I), in the absence of extracellular Ca2+. After depletion of the ER stores by CPA, a subsequent application of EtOH/POA 25 mM/25 µM (presented in grey; n = 34, N = 3) or EtOH/POA 50 mM/50 (presented in blue; n = 41, N = 3) fails to trigger further Ca2+ responses in hPSCs. M Cytosolic Ca2+ response (representative trace) to EtOH/POA 25 mM/25 µM (presented in grey; n = 14, N = 2) or EtOH/POA 50 mM/50 (presented in blue; n = 10, N = 3) in the absence of extracellular Ca2+; subsequent treatment with CPA does not trigger further Ca2+ release from the ER. Statistical significance was calculated with the Mann–Whitney test (for data presented in F) and the Kruskal–Wallis test, followed by a post hoc analysis with the Dunn test (for data presented in G, H, K).
In order to characterise the above Ca2+ signals, we carried out imaging experiments in which we disrupted intracellular Ca2+ homoeostasis either by removing extracellular Ca2+ or by incubation of cells with cyclopiazonic acid (CPA), a reversible inhibitor of the serco-endoplasmic reticulum Ca2+ ATPase (SERCA) (Fig. 1I) [24]. While EtOH/POA (10 mM/10 µM, 25 mM/25 µM and 50 mM/50 µM) induced elevation of [Ca2+]i in hPSCs in the absence of extracellular Ca2+, these responses were mostly modest and, unlike in the presence of extracellular Ca2+, returned to the baseline levels during the time course of the experiment (Fig. 1J). The magnitude of Ca2+ responses was very similar for all tested concentrations and did not show a clear concentration dependence (Fig. 1K). Inhibition of SERCA by CPA unmasked passive Ca2+ leak from the endoplasmic reticulum (ER) and led to emptying of the ER Ca2+ stores. After the application of 20 µM CPA, both EtOH/POA 25 mM/25 µM and 50 mM/50 µM failed to induce further Ca2+ signals (Fig. 1L). When the treatment was applied in reverse order, EtOH/POA 25 mM/25 µM or 50 mM/50 µM triggered a temporal [Ca2+]i increase, whereas a subsequent addition of 20 µM CPA did not have any effect (Fig. 1M). This suggests that EtOH/POA releases Ca2+ primarily from the ER store.
EtOH and POA(EE) cause activation of hPSC in vivo but not in vitro
Unlike bile-induced pancreatitis, chronic alcoholic pancreatitis is often associated with fibrosis [25, 26]. Given the above, we decided to test whether EtOH/POA is capable of activating PSCs in vivo. For this purpose, we used three different mouse models: alcoholic AP induced by EtOH (1.35 g/kg) and POA (150 mg/kg and 300 mg/kg) [27]; and two models of biliary AP, induced by taurolithocholic acid (TC-AP) or taurolithocholic acid 3-sulfate (TLC-S-AP) [28], all recently reviewed [29]. H/E staining (Fig. 2A, B, left panels) and histological scoring of the H/E-stained pancreatic tissue (Fig. 2C–E) confirm that all models demonstrated typical clinical characteristics of AP, such as prominent oedema, infiltration of immune cells in the parenchyma, and patchy or diffused acinar cell necrosis. POA at 300 mg/kg was substantially more harmful compared to POA at 150 mg/kg (Fig. 2A, left panel). Immunofluorescence staining for alpha-smooth muscle actin (α-SMA) was used to assess the extent of PSC activation in vivo and, therefore, the potential of the tissue to develop fibrotic complications. A scattered pattern of α-SMA staining was present in the whole tissue in the alcoholic model (Fig. 2A, right panels). In the biliary models, the staining was restricted to necrotic regions of the tissue damaged by the infusion of bile salts and was completely absent in the healthy regions (Fig. 2B, right panels). Quantification of the fluorescence signal showed a clear, statistically significant increase of α-SMA expression in the group treated with EtOH and POA 300 mg/kg (Fig. 2F). However, in vitro experiments revealed that EtOH and FAs do not cause upregulation of α-SMA in PSCs directly, as shown by immunofluorescence staining of hPSCs fixed after 24 h treatment with EtOH/POA(EE) (Fig. 2G, H), Western blot for α-SMA (Fig. 2I and Supplementary Fig. 1) and comparison of ACTA2 transcript levels (Fig. 2J). The above results indicate that the activation of PSCs in vivo, as evidenced by the expression pattern of α-SMA, was not due to the direct effect of EtOH/POA(EE) on these cells.
A Alcoholic AP was induced by intraperitoneal injection of ethanol (1.5 g/kg) and palmitoleic acid (POA, 150 or 300 mg/kg, n = 6 for both) in the presence of PEG 200 (1 g/kg), twice at 1 h intervals. Control mice received saline injections (n = 6). H/E staining shows an increasing severity of inflammation with increasing doses of POA (left panels). IHF staining shows a dose-dependent increase in α-SMA expression (presented in white) throughout pancreatic tissue (right panels). Scale bars: 50 µm. B Two models of bile acid-induced AP: taurocholate (TC)-elicited acute pancreatitis (TC-AP) was induced by retrograde pancreatic ductal injection with 1% TC (5 µl/min over 10 min by infusion pump, n = 5); taurolithocholic acid 3-sulfate (TLC-S)-elicited acute pancreatitis (TLC-S-AP) was induced by retrograde pancreatic ductal injection with 3 mM TLC-S (5 µl/min over 10 min by infusion pump, n = 5); for both models, saline injections (sham) were experimental controls (n = 3). Although H/E staining confirms severe inflammation, α-SMA expression is limited only to necrotic areas (inserts shown in red frames) but is absent in live tissue. Scale bars: 50 µm. C–E Histological scoring of H/E staining was done on ten random fields of view by “blinded” investigators. The severity of each parameter – oedema (C), inflammatory cell infiltration (D) and acinar cell necrosis (E)—was scored using a 4-level grade [28, 51]. Results were presented as mean ± SEM. F α-SMA expression was quantified as a ratio of α-SMA-positive area to total tissue area (QuPath Software) [52]. Calculations were carried out in ten random fields of view by “blinded” investigators. Where applicable, live and necrotic areas were identified in transmitted light images. Results were presented as mean ± SEM. Statistical significance was calculated using Welch’s ANOVA with Games-Howell’s post hoc test (alcoholic AP) and Kruskal–Wallis and Dunn’s post hoc test (biliary AP and infiltration in alcoholic AP). G Activation of human PSCs was assessed after incubation with EtOH 200 mM, EtOH/POA 10 mM/10 µM or EtOH/POAEE 100 mM/100 µM for 24 h. The expression of α-SMA (green) is an indicator of the activated phenotype. Cell nuclei are shown in blue. Scale bar: 100 µm. H Calculated proportion of α-SMA-positive cells (±SEM) in immunostaining presented in G. Cells were counted in five random fields of view for each of three biological replicates. Individual values are presented as dots. I Representative Western blot for α-SMA in hPSC after incubation with EtOH 200 mM, EtOH/POA 10 mM/10 µM or EtOH/POAEE 100 mM/100 µM for 24 h. Vinculin was used as a loading control. J Relative gene expression of ACTA2 (±SEM) in hPSC after incubation with given concentrations of ethanol, POA or POAEE (EtOH 200 mM; EtOH/POA 10 mM/10 µM; EtOH/POAEE 100 mM/100 µM) for 24 h. Expression was normalised to glyceraldehyde-3-phosphate dehydrogenase (GAPDH; N = 3). Statistical significance was calculated using the one-way ANOVA test followed by a post hoc analysis with the Dunnett test.
Activation of hPSCs has a profound effect on pathophysiological Ca2+ responses
Since EtOH/POA(EE) induce substantial [Ca2+]i responses in hPSCs in vitro, and alcoholic AP is associated with the activation of PSCs in vivo, we next examined whether the phenotype transition could affect Ca2+ homoeostasis and contribute to the development of the disease and its complications. To achieve this, we applied an in vitro model of hPSCs activated by TGF-β (5 ng/ml) either for 48 h (ahPSC 48 h) or 7 days (ahPSC 7 days). The phenotype of hPSCs was confirmed by immunofluorescence staining for α-SMA (Fig. 3A–C). After 48 h incubation, ~60% of cells were positive for α-SMA; and after 7 days, essentially all hPSCs were activated (Fig. 3D). Ca2+ elevation induced by EtOH/POA 10 mM/10 µM was almost completely abolished in ahPSCs 48 h and 7 d compared to qhPSCs (Fig. 3E–H). EtOH/POA 25 mM/25 µM induced substantially reduced Ca2+ responses in ahPSCs (Fig. 3I–L); and a similar reduction was observed in ahPSCs treated with EtOH/POA 50 mM/50 µM (Fig. 3M–P). Very notable attenuation of Ca2+ responses also occurred in ahPSCs 48 h and 7 d treated with EtOH/POAEE 100 mM/100 µM (Fig. 3Q–T) and 200 mM/200 µM (Fig. 3U–X). For most of the above treatments, Ca2+ signals in ahPSCs were not only reduced, but also more transient, with a tendency to return to the basal levels in the time course of the experiment.
A–C Activation of hPSCs was induced by incubation with TGF-β (5 ng/ml) for 48 h or 7 days. The expression of α-SMA (green) is an indicator of the activated myofibroblast-like phenotype. Cell nuclei are shown in blue. Scale bar: 30 µm. D Calculated proportion of α-SMA-positive cells (±SEM) in immunostaining presented in A–C. Cells were counted in five random fields of view for each staining. Individual values are presented as dots. E–G The average traces (±SEM) show cytosolic Ca2+ responses to 10 mM EtOH and 10 µM POA in quiescent hPSCs (n = 21; E), TGF-β-activated hPSCs for 48 h (n = 12; F) and TGF-β-activated hPSCs for 7 days (n = 30; G). H The bar graph shows the average response amplitude (±SEM) calculated between 200 and 800 s for the traces averaged in E–G. Individual values are presented as dots. I–K The average traces (±SEM) show cytosolic Ca2+ responses to 25 mM EtOH and 25 µM POA in quiescent hPSCs (n = 24; I), TGF-β-activated hPSCs for 48 h (n = 23; J), and TGF-β-activated hPSCs for 7 days (n = 27; K). L The bar graph shows the average response amplitude (±SEM) calculated between 200 and 800 s for the traces averaged in I–K. Individual values are presented as dots. M–O The average traces (±SEM) show cytosolic Ca2+ responses to 50 mM EtOH and 50 µM POA in quiescent hPSCs (n = 29; M presented previously in Fig. 1D), TGF-β-activated hPSCs for 48 h (n = 23; N), and TGF-β-activated hPSCs for 7 days (n = 20; O). P The bar graph shows the average response amplitude (±SEM) calculated between 200 and 800 s for the traces averaged in M–O. Individual values are presented as dots. Q–S The average traces (±SEM) show cytosolic Ca2+ responses to 100 mM EtOH and 100 µM POAEE in quiescent hPSCs (n = 27; Q), TGF-β-activated hPSCs for 48 h (n = 28; R) and TGF-β-activated hPSCs for 7 days (n = 13; S). T The bar graph shows the average response amplitude (±SEM) calculated between 200 and 800 s for the traces averaged in Q–S. Individual values are presented as dots. U–W The average traces (±SEM) show cytosolic Ca2+ responses to 200 mM EtOH and 200 µM POAEE in quiescent hPSCs (n = 25; U), TGF-β-activated hPSCs for 48 h (n = 13; V) and TGF-β-activated hPSCs for 7 days (n = 15; W). X The bar graph shows the average response amplitude (±SEM) calculated between 200 and 800 s for the traces averaged in U–W. Individual values are presented as dots. Statistical significance was calculated with the Kruskal–Wallis test, followed by a post hoc analysis with Dunn's test.
Expression of Ca2+ channels and transporters changes in ahPSCs
Since ahPSCs show a different pattern of Ca2+ responses compared to qhPSCs, it is likely that not only the expression of cytoskeletal proteins changes upon PSC activation, but also proteins involved in Ca2+ homoeostasis become up/down-regulated in ahPSCs. To test this hypothesis, we compared the expression of selected mRNA targets encoding cytoskeletal or ECM proteins as well as proteins engaged in Ca2+ transport and release between qhPSCs and ahPSCs (48 h and 7 days). Activation of hPSCs was evidenced by upregulated expression of the ACTA2 gene, encoding α-SMA (Fig. 4A). After the initial burst of ACTA2 expression in 48 h post-activation with TGF-β, the expression of ACTA2 stabilised at a somewhat lower level after 7 days (Fig. 4A). VIM (encoding Vimentin) increased marginally both in ahPSCs 48 h and 7 days (Fig. 4B). DES (Desmin) was elevated only after 7 days of incubation with TGF-β (Fig. 4C); in contrast, FN (Fibronectin) showed an increase in ahPSCs 48 h, but not in ahPSCs 7 days (Fig. 4D). The expression of several tested Ca2+ handling proteins initially decreased at 48 h, only to return to baseline levels after a 7-day incubation: STIM1 (Fig. 4E), ORAI1 (Fig. 4F), TRPC3 (Fig. 4G), PMCA4 (Fig. 4J), ITPR3 (Fig. 4M) and RYR2 (Fig. 4O). This was inversely correlated with a particularly high expression of ACTA2 in ahPSCs 48 h (Fig. 4A). TRPC6 was only elevated after 7 days after activation (Fig. 4H); ITPR1 (Fig. 4K), ITPR2 (Fig. 4L) and RYR1 (Fig. 4N) did not change much in ahPSCs; and RYR3 (Fig. 4P) was only slightly increased after 48 h. However, only one target of the tested mRNAs was consistently decreased in both ahPSCs 48 h and 7 d: TRPA1 (Fig. 4I).
Relative mRNA levels (qPCRs) of selected targets (±SEM) in quiescent hPSC (blue) hPSCs activated with TGF-β (5 ng/ml) for 48 h (green) and for 7 days (grey): A actin alpha 2, smooth muscle (ACTA2); B vimentin (VIM); C desmin (DES); D fibronectin (FN); E stromal interaction molecule 1 (STIM1); F calcium release-activated calcium channel protein 1 (ORAI1); G transient receptor potential cation channel, subfamily C, member 3 (TRPC3); H transient receptor potential cation channel, subfamily C, member 6 (TRPC6); I transient receptor potential ankyrin 1 channel (TRPA1); J plasma membrane calcium ATPase, isoform 4 (PMCA4); K inositol 1,4,5-trisphosphate receptor type 1 (ITPR1); L inositol 1,4,5-trisphosphate receptor type 2 (ITPR2); M inositol 1,4,5-trisphosphate receptor type 3 (ITPR3); N ryanodine receptor type 1 (RYR1); O ryanodine receptor type 2 (RYR2); P ryanodine receptor type 3 (RYR3). Expression was normalised to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (n = 2, N = 3). Statistical significance was calculated using the one-way ANOVA test followed by a post hoc analysis with the Dunnett test. ns non-significant difference, *p < 0.05, **p < 0.01; ***p < 0.001.
EtOH/POA-induced Ca2+ responses and cell death in hPSCs are regulated by TRPA1
TRPA1 caught our interest since its expression in qhPSCs could contribute to [Ca2+]i overload in these cells but not in ahPSCs. To further investigate this, we inhibited TRPA1 with HC-030031 or silenced TRPA1 expression with selective siRNA in qhPSCs (Fig. 5A). siRNA decreased levels of the TRPA1 channel, as shown by immunofluorescence staining for α-SMA and TRPA1 (Fig. 5B). This downregulation was very similar to what occurred upon activation of hPSCs. Importantly, neither pharmacological inhibition nor TRPA1 suppression caused upregulation of α-SMA on its own (Fig. 5B). However, both pharmacological inhibition and silencing of TRPA1 resulted in a very significant decrease in EtOH/POA-induced [Ca2+]i elevation, almost perfectly mirroring the responses recorded in ahPSCs 48 h (Fig. 5C, D, respectively). The average area and amplitude of these responses were not significantly different from the respective values for ahPSC 48 h (Fig. 5E, F), suggesting that TRPA1 is a major contributor to the Ca2+ overload caused by EtOH/POA in qhPSCs. Finally, we wanted to test whether the reduced Ca2+ influx that results from decreased expression of TRPA1 could affect the stored Ca2+ content in ahPSCs compared to qhPSCs. In fact, CPA-induced [Ca2+]i elevation was significantly lower in ahPSCs 48 h and 7 days compared to qhPSCs (Fig. 5G), as also shown by the analysis of the response areas (Fig. 5H), suggesting that the releasable pool of ER Ca2+ is likely to decrease in ahPSCs.
A Schematic illustration of the inhibition experiment: TRPA1 is a Ca2+ channel inhibited by HC-030031. B The expression of the activation marker α-SMA (upper panel, green) and TRPA1 (lower panel, red) was evaluated in quiescent hPSCs, quiescent hPSCs treated with TRPA1 inhibitor for 48 h, and quiescent hPSCs with TRPA1 knockdown and TGF-β-activated hPSCs for 48 h. Cell nuclei are shown in blue. Scale bar: 50 µm. C The average traces (±SEM) show cytosolic Ca2+ responses to EtOH/POA 50 mM/50 µM in quiescent hPSCs (n = 29, N = 3; navy; presented previously in Fig. 1D), TGF-β-activated hPSCs for 48 h (n = 23, N = 3; green; presented previously in Fig. 3N) and quiescent hPSCs incubated with HC-030031 for 5 min (n = 15, N = 3; red). D Average traces (±SEM) show cytosolic Ca2+ responses to EtOH/POA 50 mM/50 µM in quiescent hPSCs (n = 29, N = 3; navy; presented previously in Figs. 1D, 5C), TGF-β-activated hPSCs for 48 h (n = 23, N = 3; green; presented previously in Figs. 3N, 5C) and quiescent hPSCs with silenced expression of TRPA1 (n = 23, N = 3; blue). E The bar graph shows the average response area (±SEM) calculated between 200 and 1200 s for the traces averaged in C and D. F The bar graph shows the average response amplitude (±SEM) between 200 and 1200 s for the traces averaged in C and D. G The average traces ± SEM show cytosolic Ca2+ responses to the application of cyclopiazonic acid (CPA), an inhibitor of the SERCA pump, in quiescent hPSCs (n = 29, N = 3; q; navy), TGF-β-activated PSCs for 48 h (n = 28, N = 3; a48 h; green) TGF-β-activated PSCs for 7 d (n = 14, N = 3; a7d; grey). H Bar chart shows the average response area (±SEM) calculated between 200 and 800 s for the traces averaged in G. Statistical significance was calculated with the Kruskal–Wallis test, followed by a post hoc analysis with Dunn's test. The ROUT test was used to identify outliers in F.
Activated hPSCs are more resistant to cell death and this effect can be attained in quiescent hPSCs by inhibition of TRPA1
The activity of a number of Ca2+ pumps (e.g. PMCA and SERCA), transporters (e.g. NCX) or channels (e.g. STIM1-Orai1) is directly or indirectly dependent on cellular ATP levels. Prolonged elevation of [Ca2+]i could substantially affect mitochondrial functions, deplete ATP and lead to induction of cell death [30]. To test whether the differences in Ca2+ responses between qhPSCs and ahPSCs (48 h and 7 days) are reflected in and by the condition of mitochondria, we applied tetramethylrhodamine methyl ester (TMRM), a fluorescent probe that accumulates in healthy mitochondria with intact membrane potential (Fig. 6A). The application of EtOH/POA disrupted the mitochondrial potential in qhPSCs (Fig. 6B, C). This effect was relatively modest in response to low concentrations of EtOH/POA (10 mM/10 µM, no statistical significance), but EtOH/POA 25 mM/25 µM and 50 mM/50 µM caused very substantial declines in mitochondrial potential (Fig. 6C). In contrast, the effect of EtOH/POA on mitochondria was much less pronounced in ahPSCs: while EtOH/POA 25 mM/25 µM caused only marginally lower decrease in the mitochondrial potential of ahPSCs 48 h, in ahPSCs 7 d the loss of mitochondrial potential was markedly inhibited compared to qhPSCs (Fig. 6D, E). Given that both Ca2+ signalling and the condition of mitochondria control cell fate, we compared the extent of EtOH/POA-induced cell death in qhPSCs and ahPSCs using annexin V-FITC, propidium iodide (PI) and Hoechst 33258. Incubation with EtOH/POA at different concentrations for 30 min caused a dose-dependent increase in cell death of qhPSCs: apoptosis was the most prevalent at lower concentrations (10 mM/10 µM and 25 mM/25 µM), whereas necrosis was dominant in the group treated with EtOH/POA 50 mM/50 µM (Fig. 6F, G). However, in ahPSCs 48 h, there was a substantial reduction in total cell death (apoptosis and necrosis) in favour of living cells for all tested concentrations of EtOH/POA (Fig. 6F, G). This effect was even more pronounced in ahPSCs 7 days and was no longer dose-dependent in the range of EtOH/POA concentrations used (Fig. 6F, G). Importantly, pharmacological inhibition of TRPA1 protected qhPSCs from cell death induced by EtOH/POA 50 mM/50 µM, reducing apoptosis and necrosis to the levels seen in ahPSCs 48 h (Fig. 6F, G).
A Image shows mitochondrial localisation of TMRM in hPSCs. Scale bar: 10 μm. B The average traces (±SEM) show a decrease in TMRM fluorescence recorded in hPSCs in response to different concentrations of EtOH/POA: 0 (Ctrl, n = 24, N = 3), 10 (n = 14, N = 3), 25 (n = 12, N = 3) and 50 (n = 30, N = 3) mM/µM, respectively. CCCP (1 μM) was applied at the end of each experiment to attain the maximal decrease of Δψ. C The bar graph shows the average decrease (±SEM) below the baseline levels calculated between 200 and 800 s for the traces averaged in B. D Average traces (±SEM) show a decrease in TMRM fluorescence recorded in response to 25 mM EtOH and 25 µM POA in quiescent hPSCs (blue; n = 16, N = 3), TGF-β-activated PSCs for 48 h (green; n = 11, N = 3) and TGF-β-activated PSCs for 7 days (grey; n = 17, N = 3). CCCP (1 and 10 μM) was applied at the end of each experiment to attain the maximal decrease of Δψ. E The bar graph shows the average decrease (±SEM) below the baseline levels calculated between 200 and 800 s for the traces averaged in D. F Representative images of the staining of hPSCs with annexin V-FITC and propidium iodide after 30 min incubation with 50 mM EtOH and 50 µM POA: quiescent hPSCs (first column), quiescent hPSCs incubated with TRPA1 inhibitor HC-030031 (second column), TGF-β-activated hPSCs for 48 h (third column) and TGF-β-activated PSCs for 7 days (fourth column). Scale bar: 10 μm. G The bar charts show the proportion of apoptotic (green) and necrotic (red) cells ±SEM (for all groups N = 3) calculated from the staining presented in F. Statistical significance was calculated for the combined dead cells (apoptotic + necrotic) for a given concentration of EtOH/POA between qhPSC vs qhPSC + HC-030031, ahPSC 48 h and ahPSC 7 days, using one-way ANOVA followed by a post hoc analysis with the Dunnett’s T3 test. The significance between qhPSC + HC-030031 and ahPSC 48 h was calculated using the t-test.
Discussion
EtOH-induced damage to the pancreas occurs via products of non-oxidative alcohol metabolism: FAEEs generated from EtOH and FAs, such as POA [4, 7]. FAEEs are present in human plasma after EtOH ingestion and were found in particularly high amounts in the pancreata of subjects intoxicated with EtOH at the time of death [31, 32]. Recently, FAEEs have been suggested as candidate biomarkers of pancreatitis [33]. FAEEs are formed by esterification of FAs with EtOH catalysed by FAEE synthases, or by transesterification of EtOH to acyl-coenzyme A by acyl-coenzyme A:ethanol O-acyltransferase [34]. Since the pancreatic tissue is characterised by high FAEE synthase activity and FAEE hydrolase activity, comparable to that of the liver [34, 35], treatment with EtOH and POA will generate POAEE intracellularly, and vice versa. FAEEs can accumulate at the inner mitochondrial membrane [36], where they become broken down to FAs and ethanol by carboxylesterase [34].
The toxicity of alcohol metabolites is generally attributed to the generation of excessive cytosolic Ca2+ signals in PACs. This causes premature intracellular activation of digestive enzymes and failure of mitochondrial ATP production, leading to necrosis, which in turn leads to a generation of Ca2+ signals in PSCs and pancreatic immune cells [4, 7]. Although this clarifies the core mechanism of pancreatic autodigestion, inflammation, and tissue necrosis, it does not explain why PSC-mediated fibrosis is a particularly common complication of alcoholic pancreatitis. Since Ca2+ signals play a major role in the mechanism of EtOH-induced toxicity in PACs, in this study, we have focused on the Ca2+ effects of alcohol metabolites on PSCs. EtOH alone applied at high concentration only elicited a modest elevation of baseline [Ca2+]i in qhPSCs (Fig. 1C), which is similar to previous observations made in PACs [4, 37]. Importantly, both EtOH/POA and EtOH/POAEE consistently induced global and sustained elevations of [Ca2+]i in qhPSCs, in a dose-dependent manner (Fig. 1D, E, G, H), suggesting that alcohol metabolites are detrimental, not only to PACs but also to PSCs.
While the influx of extracellular Ca2+ is a significant part of EtOH/POA(EE)-induced responses, it is the release of Ca2+ from intracellular stores that is the initiating signal. This is illustrated by the fact that although the responses to EtOH/POA in qhPSCs were substantially diminished in the absence of extracellular Ca2+, they were not completely abolished (Fig. 1J, K). In PACs, the ER is the primary source of toxic [Ca2+]i elevation induced by alcohol metabolites and sustained incubation of PACs with POAEE or POA in the absence of external Ca2+ depletes the ER of Ca2+ [38]. However, Ca2+ entry from the extracellular space through Ca2+ release-activated Ca2+ channels is an absolute requirement for acinar necrosis to occur [4].
In qhPSCs, emptying the ER with CPA prevented EtOH/POA-driven Ca2+ release from intracellular stores (Fig. 1L) and CPA failed to induce any Ca2+ responses when it was applied after EtOH/POA, suggesting that the ER stores had already been depleted (Fig. 1M). While FAEEs in PACs cause toxic elevation of [Ca2+]i predominantly through Ca2+ release from the ER via IP3Rs [4], FAs act on mitochondria and disrupt ATP production, which results in Ca2+ pump failure (SERCA, PMCA) [38]. Our results show that EtOH/POA induces diminished and transient Ca2+ signals in qhPSCs in the absence of extracellular Ca2+ (Fig. 1J), resembling the elevation of [Ca2+]i triggered by the inhibition of SERCA by CPA (Fig. 1M). This similarity is consistent with the failure of Ca2+ ATPases due to the lack of ATP contributing to Ca2+ overload in qhPSCs exposed to EtOH/POA or POAEE in the presence of extracellular Ca2+. This notion is strengthened by the fact that EtOH/POA induces a loss of mitochondrial potential (Fig. 6B, C), which is inevitably associated with a substantial drop in cellular ATP levels. Indeed, FAs were previously shown to disrupt mitochondrial metabolism and inhibit respiration by uncoupling oxidative phosphorylation and opening the mitochondrial permeability transition pore [38, 39].
In this study, we have tested the capacity of different inducers of pancreatic pathology, i.e. bile acids vs ethanol metabolites, to activate PSCs in three mouse models of AP. Our new data demonstrate a marked tissue-wide elevation in α-SMA expression in the alcoholic model (Fig. 2A, B). However, this activation is clearly not due to a direct action of alcohol metabolites on PSCs, since EtOH/POA and EtOH/POAEE failed to activate qhPSCs in vitro (Fig. 2G–J). Previously, it has been suggested that rat PSCs could be activated by EtOH in vitro [20], but this does not seem to be the case for human PSCs. This issue requires further investigation as results from cultured cells may also differ from those in acutely isolated cells.
Experimental alcoholic AP shows a different pattern from experimental biliary AP, with inflammation present in the entire tissue in the former but not latter. Although the extent of this difference in human AP is not known, the perpetuation of excess ethanol consumption will continue to drive the activation of PSCs, contributing to chronicity. The presence of cytokines and inflammatory mediators likely leads to the widespread activation of PSCs manifested as increased α-SMA expression. When neighbouring PACs are damaged and undergo necrosis, they release kallikrein and trypsin [40]. Kallikrein can induce the generation of bradykinin from its precursor, which then affects Ca2+ homoeostasis in PSCs (Fig. 1B) [41]. Furthermore, Ca2+ signals in PSCs may further perpetuate necrosis and ongoing inflammation in the tissue via mechanisms that involve the production of nitric oxide [42].
Our new results for the first time show that activated PSCs develop remarkable resistance against alcohol metabolites, evidenced by significantly reduced Ca2+ responses to EtOH/POA (Fig. 3E–P) and EtOH/POAEE (Fig. 3Q–X) as well as by a marked decrease in cell death caused by EtOH/POA in ahPSCs compared to qhPSCs (Fig. 6F, G). This is particularly important for the pathogenesis of alcoholic pancreatitis. Activated PSCs will no longer be sensitive to alcohol metabolites present in the tissue and may continue to proliferate, activate the remaining quiescent cells, and deposit ECM components.
The mechanism behind the resistance of ahPSCs to alcohol metabolites lies in the enhanced Ca2+ handling capacity, compared to qhPSCs, which depends on the expression of Ca2+ channels and transporters (Fig. 4). In this study, the most important Ca2+-handling proteins were selected for analyses, including generic proteins (such as STIM1, Orai1, IP3Rs and RyRs), and those highlighted in the existing literature related to PSCs and other stellate cells/tissue fibroblasts (such as TRPA1, see below). Our results show that TRPA1 expression drops to very low levels in ahPSCs 48 h and 7 d (Fig. 4I). Pharmacological inhibition as well as silencing of TRPA1 in qhPSCs results in almost identical Ca2+ responses to EtOH/POA to those recorded in ahPSCs 48 h (Fig. 5C–F). Even more notably, the TRPA1 blocker protected against EtOH/POA-induced cell death in qhPSCs (Fig. 6F, G). Since altered Ca2+ fluxes across the plasma membrane could have an impact on the intracellular Ca2+ store content [43], downregulation of TRPA1 could contribute to the apparent decrease in the resting [Ca2+]ER of ahPSCs, unmasked by inhibition of SERCA by CPA (Fig. 5G, H). TRPA1 has previously been suggested to be protective against fibrosis in intestinal myofibroblasts, both in vitro and in a mouse model of chronic colitis [44]. Very recently, downregulation of TRPA1 by TGF-β was implicated in the resistance of lung myofibroblasts to cell death [45], although the detailed mechanism has not been investigated. Here, we have identified a remarkable downregulation of TRPA1 in ahPSCs and analysed its pathophysiological consequences in relation to pancreatitis. Given the results of this and previous studies, TRPA1 could play a central role in the regulation of cell death induced by toxic stimuli in a large spectrum of tissue (myo)fibroblasts.
In conclusion, this study sheds new light on the mechanisms underlying alcohol metabolite-induced pancreatic pathology, which involves signalling in PSCs (Fig. 7). Alcohol toxicity is mediated by EtOH, FAs, and FAEEs, which induce damage to PACs. Alcohol metabolites also act on quiescent PSCs inducing [Ca2+]i overload, disrupting the mitochondrial potential, and inducing cell death. Alcoholic pancreatitis results in the activation of PSCs throughout the pancreatic tissue. Activated PSCs become resistant to alcohol metabolites owing to their enhanced Ca2+ handling capacity compared to the quiescent cells: activated PSCs are protected against excessive [Ca2+]i overload by downregulation of TRPA1. Significant resistance of activated PSCs to noxious stimuli (such as alcohol metabolites) might explain why pancreatic fibrosis is a frequent complication of alcoholic pancreatitis. While PACs and quiescent PSCs are prone to cell death, activated PSCs can more easily withstand the ongoing inflammation, repopulate the tissue, and deposit ECM components.
Our study also, for the first time, shows that EtOH in combination with FAs directly elicits Ca2+ signals in PSCs and that these signals can be sustained in the presence of extracellular Ca2+ (Fig. 1D, E, G, H). Recent work has highlighted the key role of PSCs in inflammation by showing that the SARS-Cov-2 spike protein primarily elicits Ca2+ signals in PSCs in situ in the mouse pancreas and that these Ca2+ signals subsequently generate Ca2+ signals in pancreatic macrophages, most likely via interleukins released from the PSCs [46]. The Ca2+ signals shown in the present work to be generated in PSCs by EtOH in combination with FAs could well turn out to be an important element in the initiation of the inflammatory response, which is such a critical part of AP.
Materials and methods
Cell culture
Human pancreatic stellate cells (hPSCs, cat. #3830) and dedicated stellate cell complete medium (SteCM) were purchased from ScienCell, Carlsbad, CA, USA. hPSCs were cultured in Stem in T25 flasks at 37 °C, 5% CO2 and split once a week as previously described [23]. Immediately after the first passage, multiple frozen hPSC stocks were prepared to be used later for culture revival (approximately every 5–6 weeks). The cells are regularly tested for mycoplasma contamination (by PCR). Activated hPSCs were obtained by culturing hPSCs in the presence of 5 ng/ml TGF-β (Corning, New York, NY, USA) [47] in an “incomplete” SteCM medium i.e. deprived of foetal bovine serum (FBS) and cell growth supplements (CGS) for a set period of time (48 h or 7 days).
Animal models
Animal experiments were ethically reviewed and carried out in accordance with the Animals (Scientific Procedures) Act 1986 (UK); relevant project licence number: 30/2956. C57BL/6 J mice (males, 6–12 weeks old, 23 ± 3 g weight) were supplied by Charles River Laboratories, UK and housed in institutional animal units (Cardiff University and University of Liverpool, UK) under the following conditions: 12 h light cycle, standard rodent chow diet, free access to water. Minimisation was used as a randomisation strategy to allocate animals to different groups to balance body weight that could influence the results of the experiments [48]. The sample size was estimated and checked based on Charan and Kantharia, 2013 (E = 15 for alcoholic AP and E = 10 for biliary AP, which was considered adequate) [49]. All animals were included in the analyses. Alcoholic AP was induced by two intraperitoneal injections (1 h apart) of EtOH (1.5 g/kg) and palmitoleic acid (POA, Merck, Darmstadt, Germany; 150 or 300 mg/kg, n = 6 for both) in the presence of polyethylene glycol (PEG) 200 (1 g/kg; Merck) [27]. Control mice received saline injections (n = 6). Biliary AP was induced by retrograde pancreatic duct infusion of sodium taurocholate (NaTC 1%; NaTC-AP) and taurolithocholic acid 3-sulfate (TLC-S 3 mM; TLC-S-AP), respectively, at 5 µl/min over 10 min by infusion pump [28]; saline injections (Sham) were used as experimental controls (n = 3) for both models. Mice were sacrificed according to Schedule 1 of Animals (Scientific Procedures) Act 1986, dissected and the pancreas was removed. Pancreatic tissue was fixed in 10% formalin (for 48 h), dehydrated by subsequent incubations in solutions with increasing EtOH content: 50, 70, 96 and 100% and then in xylene and liquid paraffine. The processed samples were embedded in paraffin and cut into 5 µm thick sections for further experimental procedures.
Cytosolic Ca2+ and mitochondrial potential imaging
For calcium imaging, hPSCs cultured on Ø32 mm round coverslips were loaded with 2 μM Fluo-4 AM (Thermo Fisher Scientific, Waltham, MA, USA) for 30 min at 37 °C; whereas for mitochondrial potential measurements, cells were loaded with 25/100 nM tetramethylrhodamine methyl ester (TMRM, Thermo Fisher Scientific). Fluo-4 AM loading and all real-time imagining experiments were carried out in NaHEPES buffer (140 mM NaCl, 4.7 mM KCl, 10 mM HEPES, 1 mM MgCl2, 10 mM glucose; pH 7.2; supplemented with 1 mM CaCl2) [23]. After loading, cells were washed with fresh NaHEPES buffer and used for experiments at room temperature (RT) in a flow chamber perfused with NaHEPES-based extracellular solution. All measurements of Ca2+/mitochondrial potential were performed on the ZEISS LSM 880 confocal microscope (Carl Zeiss AG, Oberkochen, Germany), 40× oil objective. Fluo-4-loaded cells were excited with 488 nm laser light, and collected fluorescence was set to 593–630 nm. For the cells loaded with TMRM, the excitation wavelength was 561 nm and the collected emission was set in the range of 579–721 nm. Time series were recorded at 256 × 256 pixel resolution, two consecutive frames were averaged, and the interval between images was 2 s. Fluorescence signals were plotted as F/F0, where F0 was an averaged value calculated from the initial ten baseline images. The area under the curve was calculated for each trace. The average values obtained for each experimental group were presented as bar charts (mean ± SEM) with all individual points shown. For TRPA1 inhibition experiments, a 5-min preincubation with HC-030031 (Merck) was applied immediately before calcium recording. The inhibitor was present throughout the entire experiment. For all Ca2+ experiments, a pre-defined exclusion criterion was used: spontaneous activity higher than 3×(baseline values) before the application of any stimulus.
RNA isolation, reverse transcription and real-time PCR
RNA was isolated from cells cultured on 6-well plates using the Total RNA Mini Kit (A&A Biotechnology, Gdynia, Poland) according to the manufacturer’s protocol. RNA concentration was measured with an ND-1000 spectrophotometer (Thermo Fisher Scientific). Equal amounts of total RNA (1 µg) were taken for cDNA synthesis using the High Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific) and following the manufacturer’s protocol. For real-time PCR assays, SYBR Green PCR Mix (Thermo Fisher Scientific) was used. Specific gene primer pairs (Genomed, Warsaw, Poland) are listed in Table 1. The real-time PCR reaction was performed using a 7500 Fast Real-Time PCR thermocycler (Applied Biosystems, Waltham, MA, USA). Reaction conditions were as follows: 50 °C (20 sec), 95 °C (5 min); then 40 cycles of 95 °C (15 sec) and 60 °C (1 min) each. Relative gene expression was calculated as the cycle threshold value (Ct) normalised to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) using the 2(–∆∆Ct) method [50].
Protein isolation and Western blotting
PSCs were lysed in RIPA buffer (Merck) supplemented with a protein inhibitor cocktail (Sigma) and the protein concentration was measured using a bicinchoninic acid assay (Sigma). 20 µg protein samples were separated by SDS-PAGE and then transferred onto polyvinylidene fluoride membranes (wet transfer, 1 h, 30 V) in an XCell SureLock® Blot Module (Thermo Fisher Scientific). To prevent non-specific binding, membranes were incubated in 5% (w/v) skimmed milk in TBST (0.05% (v/v) Tween 20 in Tris-buffered saline). The membranes were then incubated overnight at 4 °C with primary antibodies (A2547, V9131, Merck) in antibody buffer containing 1% (w/v) milk in TBST, washed with TBST three times and incubated with peroxidase-labelled secondary antibody (PI-2000, Vector Laboratories) in the same antibody buffer. Detection was performed with the chemiluminescence HRP substrate (Merck) in the Bio-Rad ChemiDoc imager.
Histopathology and histological scoring
Haematoxylin/eosin (H/E) staining was carried out as previously described [28, 51]. Briefly, formalin-fixed paraffin-embedded tissue sections (5 μm) were deparaffinised by heating in a dry oven (15 min, 65 °C) followed by two consecutive 10 min incubations in xylene. Rehydration was achieved by subsequent washes in EtOH solutions with increasing content of deionized H2O (dH2O): twice in 100% EtOH, then once in 96, 70 and 50% EtOH, and finally in dH2O. Sections were stained in Mayer’s haematoxylin solution (Merck) for 12 min, and then washed in running tap water (15 min). The sections were then incubated in 0.5% eosin Y solution with phloxine (Merck) (90 s). Subsequently, the sections were dehydrated in solutions with an increasing EtOH content: 70, 96 and 100% followed by washing in xylene. The slides were sealed with Histofluid mounting medium (Paul Marienfeld, Lauda-Königshofen, Germany). Microscopic evaluation of H/E samples was carried out by assessing 10 random fields of view in a ‘blind’ manner. The severity of each parameter—oedema, inflammatory cell infiltration, and acinar cell necrosis—was scored using a four-level grade [28].
Immunocytofluorescence
hPSCs were seeded on Ø13 mm round glass coverslips and incubated for 24 h in an 'incomplete' SteCM with ethanol (Chempur, Piekary Slaskie, Poland) and POA or POEE. After washing with phosphate-buffered saline (PBS), cells were fixed in methanol (Avantor Performance Materials, Gliwice, Poland) for 20 min at −20 °C. Methanol was removed by three washes in PBS (5 min each) and blocking of non-specific binding sites was achieved by incubation in 2% BSA in PBS for 30 min (shaker, RT). Primary mouse antibody anti-αSMA (ab7817, Abcam, Cambridge, UK) and/or rabbit anti-TRPA1 (NB110-40763, Novus Biologicals, Biotechne) were applied in 1:300 dilution in 1% BSA for 1 h at RT. The fixed cells were then washed three times in PBS (5 min each) and incubated with the secondary goat anti-mouse antibody Alexa Fluor 488 and/or goat anti-rabbit antibody Alexa Fluor 635 (A11001, A31576, Thermo Fisher Scientific) (1:500 dilution, 30 min, RT). After washing in PBS (four times, 5 min each) and rinsing in dH2O, the slides were sealed with ProLong Diamond Antifade Mountant with DAPI (Thermo Fisher Scientific). Imaging was done with a ZEISS LSM 880 confocal microscope.
Immunohistofluorescence
For immunohistofluorescence (IHF), a previously established protocol was used with modifications [23]. Before the staining, formalin-fixed paraffin-embedded tissue sections (5 μm) were deparaffinised by heating in a dry oven (15 min, 65 °C) followed by two consecutive 10 min incubations in xylene. The sections were rehydrated by subsequent washes in ethanol solutions as described above for H/E staining. The sections were then incubated in 50 mM NH4Cl (Merck) in dH2O (30 min). Subsequently, heat-induced antigen retrieval was carried out in TAE buffer (Merck) (pH 8.1) in an autoclave (20 min, 120 °C) and then the sections were allowed to cool at RT for 30 min before permeabilisation in 0.4% Triton X-100 (Avantor Performance Materials) in dH2O (10 min). Later, the sections were washed three times (5 min each) in 0.1% Tween 20 in dH2O ('washing solution'). In order to quench autofluorescence of the pancreas, the sections were incubated in 0.2% Sudan Black B (Merck) in 70% EtOH for 20 min and washed four times (5 min each) in a washing solution. Blocking of non-specific binding sites was achieved by 1 h incubation in 1% BSA in PBS with 0.1% Tween 20. The sections were then incubated with anti-α SMA antibody (ab7817, Abcam, Cambridge, UK) in 1:300 dilution in the blocking buffer overnight at 4 °C in a humidity chamber. The following day, the sections were washed four times (5 min each) in the washing solution and incubated for 1 h at RT with the secondary goat anti-mouse antibody Alexa Fluor 488 (A11001, Thermo Fisher Scientific) (1:500 dilution in blocking buffer, 30 min, RT). After incubation, the sections were washed four times (5 min each) in the washing solution, embedded in ProLong Diamond Antifade Mountant with DAPI and imaged immediately using the ZEISS LSM 880 confocal microscope. The slides were then stored at 4 °C. QuPath software was used for quantitative analysis of the staining [52].
Cell death assay
hPSCs were plated on Ø32 mm glass coverslips and grown for 24 h in SteCM or activated with TGF-beta (5 ng/ml) in an incomplete medium (SteCM without FBS/CGS) at 37 °C. The medium was then replaced with NaHEPES buffer containing EtOH and POA of a given concentration; and the hPSCs were incubated for 30 min at 37 °C. 15 min before the end of the incubation, annexin V-FITC (1 µg/mL), propidium iodide (PI, 1 μg/mL) and Hoechst-33342 (5 μg/mL) (all from Thermo Fisher Scientific) were added. Green annexin V-FITC staining was used to detect apoptotic cells, PI stained necrotic cells, and Hoechst stained nuclei. Multiple random images (15) per treatment group were taken using the ZEISS LSM 880 confocal microscope. Apoptotic, necrotic, and live cells were counted in images of each treatment group, and the results were presented as a percentage of all cells.
RNA interference-mediated gene silencing
hPSCs were cultured up to 50% confluence on glass coverslips. The cells were then transfected with 20 nM siRNA targeted against human TRPA1 (Thermo Fisher Scientific) pre-mixed with RNAiMAX Lipofectamine (SilencerTM Select, Thermo Fisher Scientific), according to the manufacturer’s protocol. The siRNA-lipid complex was prepared in Opti-MEM medium (Gibco), incubated for 5 min, and added to the cells. After 72 h of transfection, cells were used for cytosolic Ca2+ imaging and immunocytofluorescence staining. As a negative control, mock siRNA was used (SilencerTM Select Negative Control No. 1 siRNA, Thermo Fisher Scientific).
Statistical analysis
For cell death assays, three independent experiments were carried out for each treatment group. The average values and standard errors of the mean were calculated and the results were presented as bar charts. For quantitative analysis of Ca2+ responses or measurements of the mitochondrial potential, areas under individual traces (over baseline) were calculated and then averaged and presented as bar charts with standard errors of the mean and individual data points. Statistical analysis was performed with GraphPad software. For cell-based experiments, no statistical tools were applied to pre-estimate sample size. In animal models, group size was estimated based on Charan and Kantharia, 2013 [49]. Normality of the data was assessed with the Shapiro–Wilk test and homogeneity of variances with the Levene test. In cases when the date did not pass the normality test, a non-parametric statistical test was applied. The significance threshold was set at the p value = 0.05 and, when applicable, was adjusted for multiple comparisons. Statistical tests used for data analysis are indicated in each figure legend. Where applicable, N indicates the number of independent experimental replicates, while n indicates individual cells.
Data availability
All relevant data are included in the article. Raw data from individual experiments will be made available upon request.
References
Spanier BW, Dijkgraaf MG, Bruno MJ. Epidemiology, aetiology and outcome of acute and chronic pancreatitis: an update. Best Pr Res Clin Gastroenterol. 2008;22:45–63.
Yadav D, Whitcomb DC. The role of alcohol and smoking in pancreatitis. Nat Rev Gastroenterol Hepatol. 2010;7:131–45.
Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol. 2019;16:175–84.
Petersen OH, Gerasimenko JV, Gerasimenko OV, Gryshchenko O, Peng S. The roles of calcium and ATP in the physiology and pathology of the exocrine pancreas. Physiol Rev. 2021;101:1691–744.
Raraty M, Ward J, Erdemli G, Vaillant C, Neoptolemos JP, Sutton R, et al. Calcium-dependent enzyme activation and vacuole formation in the apical granular region of pancreatic acinar cells. Proc Natl Acad Sci USA. 2000;97:13126–31.
Criddle DN, Raraty MGT, Neoptolemos JP, Tepikin AV, Petersen OH, Sutton R. Ethanol toxicity in pancreatic acinar cells: mediation by nonoxidative fatty acid metabolites. Proc Natl Acad Sci. USA. 2004;101:10738–43.
Petersen OH, Tepikin AV, Gerasimenko JV, Gerasimenko OV, Sutton R, Criddle DN. Fatty acids, alcohol and fatty acid ethyl esters: toxic Ca2+ signal generation and pancreatitis. Cell Calcium. 2009;45:634–42.
Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998;43:128–33.
Pareja E, Artigues E, Mir J, Fabra R, Martinez V, Vazquez A, et al. Main pancreatic duct: morphlogy after acute biliary pancreatitis with magnetic resonance cholangiopancreatography after secretin stimulation. Rev Esp Enferm Dig. 2003;95:389–94.
Bertilsson S, Sward P, Kalaitzakis E. Factors that affect disease progression after first attack of acute pancreatitis. Clin Gastroenterol Hepatol. 2015;13:1662–9.e3.
Ahmed Ali U, Issa Y, Hagenaars JC, Bakker OJ, van Goor H, Nieuwenhuijs VB, et al. Risk of recurrent pancreatitis and progression to chronic pancreatitis after a first episode of acute pancreatitis. Clin Gastroenterol Hepatol. 2016;14:738–46.
Ferdek PE, Jakubowska MA. Biology of pancreatic stellate cells - more than pancreatic cancer. Pflugers Arch. 2017;469:1039–50.
Ferdek PE, Krzysztofik D, Stopa KB, Kusiak AA, Paw M, Wnuk D, et al. When healing turns into killing - the pathophysiology of pancreatic and hepatic fibrosis. J Physiol. 2022;600:2579–612.
Erkan M, Adler G, Apte MV, Bachem MG, Buchholz M, Detlefsen S, et al. StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut 2012;61:172–8.
Kusiak AA, Szopa MD, Jakubowska MA, Ferdek PE. Signaling in the physiology and pathophysiology of pancreatic stellate cells - a brief review of recent advances. Front Physiol. 2020;11:78.
Apte M, Pirola RC, Wilson JS. Pancreatic stellate cell: physiologic role, role in fibrosis and cancer. Curr Opin Gastroenterol. 2015;31:416–23.
Phillips P. Pancreatic stellate cells and fibrosis. In: Grippo PJ, Munshi HG, editors. Pancreatic cancer and tumor microenvironment. Trivandrum: Transworld Research Network; 2012.
Braganza JM, Lee SH, McCloy RF, McMahon MJ. Chronic pancreatitis. Lancet. 2011;377:1184–97.
Stopa KB, Kusiak AA, Szopa MD, Ferdek PE, Jakubowska MA. Pancreatic cancer and its microenvironment-recent advances and current controversies. Int J Mol Sci. 2020;21:3218.
Apte MV, Phillips PA, Fahmy RG, Darby SJ, Rodgers SC, McCaughan GW, et al. Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology 2000;118:780–94.
Won JH, Zhang Y, Ji B, Logsdon CD, Yule DI. Phenotypic changes in mouse pancreatic stellate cell Ca2+ signaling events following activation in culture and in a disease model of pancreatitis. Mol Biol Cell. 2011;22:421–36.
Gryshchenko O, Gerasimenko JV, Gerasimenko OV, Petersen OH. Ca2+ signals mediated by bradykinin type 2 receptors in normal pancreatic stellate cells can be inhibited by specific Ca2+ channel blockade. J Physiol. 2016;594:281–93.
Ferdek PE, Jakubowska MA, Gerasimenko JV, Gerasimenko OV, Petersen OH. Bile acids induce necrosis in pancreatic stellate cells dependent on calcium entry and sodium-driven bile uptake. J Physiol. 2016;594:6147–64.
Plenge-Tellechea F, Soler F, Fernandez-Belda F. On the inhibition mechanism of sarcoplasmic or endoplasmic reticulum Ca2+-ATPases by cyclopiazonic acid. J Biol Chem. 1997;272:2794–800.
Kleeff J, Whitcomb DC, Shimosegawa T, Esposito I, Lerch MM, Gress T, et al. Chronic pancreatitis. Nat Rev Dis Prim. 2017;3:17060.
Pandol SJ, Raraty M. Pathobiology of alcoholic pancreatitis. Pancreatology 2007;7:105–14.
Huang W, Booth DM, Cane MC, Chvanov M, Javed MA, Elliott VL, et al. Fatty acid ethyl ester synthase inhibition ameliorates ethanol-induced Ca2+-dependent mitochondrial dysfunction and acute pancreatitis. Gut 2014;63:1313–24.
Huang W, Cane MC, Mukherjee R, Szatmary P, Zhang X, Elliott V, et al. Caffeine protects against experimental acute pancreatitis by inhibition of inositol 1,4,5-trisphosphate receptor-mediated Ca2+ release. Gut 2017;66:301–13.
Yang X, Yao L, Fu X, Mukherjee R, Xia Q, Jakubowska MA, et al. Experimental acute pancreatitis models: history, current status, and role in translational research. Front Physiol. 2020;11:614591.
Criddle DN, Gerasimenko JV, Baumgartner HK, Jaffar M, Voronina S, Sutton R, et al. Calcium signalling and pancreatic cell death: apoptosis or necrosis? Cell Death Differ. 2007;14:1285–94.
Doyle KM, Bird DA, al-Salihi S, Hallaq Y, Cluette-Brown JE, Goss KA, et al. Fatty acid ethyl esters are present in human serum after ethanol ingestion. J Lipid Res. 1994;35:428–37.
Laposata EA, Lange LG. Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science. 1986;231:497–9.
Vela S, Guerra A, Farrell G, Trivedi S, Chaffin H, Rood C, et al. Pathophysiology and biomarker potential of fatty acid ethyl ester elevation during alcoholic pancreatitis. Gastroenterology. 2021;161:1513–25.
Diczfalusy MA, Bjorkhem I, Einarsson C, Hillebrant CG, Alexson SE. Characterization of enzymes involved in formation of ethyl esters of long-chain fatty acids in humans. J Lipid Res. 2001;42:1025–32.
Aleryani S, Kabakibi A, Cluette-Brown J, Laposata M. Fatty acid ethyl ester synthase, an enzyme for nonoxidative ethanol metabolism, is present in serum after liver and pancreatic injury. Clin Chem. 1996;42:24–7.
Lange LG, Sobel BE. Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanol. J Clin Invest. 1983;72:724–31.
Gerasimenko JV, Lur G, Ferdek P, Sherwood MW, Ebisui E, Tepikin AV, et al. Calmodulin protects against alcohol-induced pancreatic trypsinogen activation elicited via Ca2+ release through IP3 receptors. Proc Natl Acad Sci USA. 2011;108:5873–8.
Criddle DN, Murphy J, Fistetto G, Barrow S, Tepikin AV, Neoptolemos JP, et al. Fatty acid ethyl esters cause pancreatic calcium toxicity via inositol trisphosphate receptors and loss of ATP synthesis. Gastroenterology. 2006;130:781–93.
Penzo D, Tagliapietra C, Colonna R, Petronilli V, Bernardi P. Effects of fatty acids on mitochondria: implications for cell death. Biochim Biophys Acta. 2002;1555:160–5.
Griesbacher T, Rainer I, Tiran B, Fink E, Lembeck F, Peskar BA. Mechanism of kinin release during experimental acute pancreatitis in rats: evidence for pro- as well as anti-inflammatory roles of oedema formation. Br J Pharm. 2003;139:299–308.
Gryshchenko O, Gerasimenko JV, Peng S, Gerasimenko OV, Petersen OH. Calcium signalling in the acinar environment of the exocrine pancreas: physiology and pathophysiology. J Physiol. 2018;596:2663–78.
Jakubowska MA, Ferdek PE, Gerasimenko OV, Gerasimenko JV, Petersen OH. Nitric oxide signals are interlinked with calcium signals in normal pancreatic stellate cells upon oxidative stress and inflammation. Open Biol. 2016;6:160149.
Ferdek PE, Gerasimenko JV, Peng S, Tepikin AV, Petersen OH, Gerasimenko OV. A novel role for Bcl-2 in regulation of cellular calcium extrusion. Curr Biol. 2012;22:1241–6.
Kurahara LH, Hiraishi K, Hu Y, Koga K, Onitsuka M, Doi M, et al. Activation of myofibroblast TRPA1 by steroids and pirfenidone ameliorates fibrosis in experimental Crohn’s disease. Cell Mol Gastroenterol Hepatol. 2018;5:299–318.
Virk HS, Biddle MS, Smallwood DT, Weston CA, Castells E, Bowman VW, et al. TGFbeta1 induces resistance of human lung myofibroblasts to cell death via down-regulation of TRPA1 channels. Br J Pharm. 2021;178:2948–62.
Gerasimenko JV, Petersen OH, Gerasimenko OV. SARS-CoV-2 S protein subunit 1 elicits Ca2+ influx - dependent Ca2+ signals in pancreatic stellate cells and macrophages in situ. Function. 2022;3:zqac002.
Wnuk D, Paw M, Ryczek K, Bochenek G, Sladek K, Madeja Z, et al. Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-beta/Smad2/3 pathway intensification and antifibrotic TGF-beta/Smad1/5/(8)9 pathway impairment. Sci Rep. 2020;10:16492.
Altman DG, Bland JM. Treatment allocation by minimisation. BMJ 2005;330:843.
Charan J, Kantharia ND. How to calculate sample size in animal studies? J Pharm Pharmacother. 2013;4:303–6.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8.
Wen L, Voronina S, Javed MA, Szatmary P, Latawiec D, Chvanov M, et al. Inhibitors of ORAI1 prevent cytosolic calcium-associated injury of human pancreatic acinar cells and acute pancreatitis in 3 mouse models. Gastroenterology. 2015;149:481–92.
Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7:16878.
Acknowledgements
This work was funded by (1) the HOMING/2017-4/31 project grant (to PEF) carried out within the HOMING programme of the Foundation for Polish Science (Fundacja na rzecz Nauki Polskiej, FNP), cofinanced by the European Union under the European Regional Development Fund; and (2) the OPUS project No. 2019/33/B/NZ3/02578 (to PEF) of the National Science Center of Poland (Narodowe Centrum Nauki, NCN). AAK was an MSc/PhD student employed on the HOMING/2017-4/31 grant and then the OPUS project (2019/33/B/NZ3/02578). MAJ and KBS were supported by the HOMING/2017-3/23 project grant (to MAJ) and WH was funded by the National Natural Science Foundation of China (No. 81973632). RS is supported by a National Institute for Health and Care Research Senior Investigator award. Figures 1I, 5A and 7 were created in BioRender.com (with minor modifications introduced later) and respective agreement numbers are YM238JSBLP, ER23IJY1RI and IS23IJXOQK. Primers for FN are a kind gift from Dr. Milena Paw (Jagiellonian University in Krakow, Poland).
Author information
Authors and Affiliations
Contributions
PEF: initial concept and design. AAK, PEF, MAJ, KBS, XZ and WH: acquisition, analysis or interpretation of data. PEF and AAK: figure preparation and drafting of the manuscript. PEF, MAJ, WH, JVG, OVG, RS and OHP: contribution to the conceptualisation and critical revision of the manuscript. AAK: statistical analysis. PEF: obtained funding. PEF, RS and OHP: supervision of experimental work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by Professor Anastasis Stephanou
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kusiak, A.A., Jakubowska, M.A., Stopa, K.B. et al. Activation of pancreatic stellate cells attenuates intracellular Ca2+ signals due to downregulation of TRPA1 and protects against cell death induced by alcohol metabolites. Cell Death Dis 13, 744 (2022). https://doi.org/10.1038/s41419-022-05186-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-022-05186-w
- Springer Nature Limited
This article is cited by
-
Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis
BMC Medicine (2023)
-
Transient receptor potential ankyrin 1 (TRPA1) mediates reactive oxygen species-induced Ca2+ entry, mitochondrial dysfunction, and caspase-3/7 activation in primary cultures of metastatic colorectal carcinoma cells
Cell Death Discovery (2023)
-
Compromised diabetic heart function is not affected by miR-378a upregulation upon hyperglycemia
Pharmacological Reports (2023)
-
The anti-inflammatory effect of dimethyl trisulfide in experimental acute pancreatitis
Scientific Reports (2023)